Andrea Liapis Jackson - Jun 9, 2022 Form 4/A - Amendment Insider Report for Codex DNA, Inc. (TBIO)

Role
Director
Signature
/s/ Jennifer McNealey, as Attorney-in-Fact
Stock symbol
TBIO
Transactions as of
Jun 9, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
6/15/2022, 04:35 PM
Date Of Original Report
Jun 13, 2022
Previous filing
Jun 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TBIO Common Stock 0 Jun 9, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TBIO Stock Option (right to buy) 0 Jun 9, 2022 Common Stock 0 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 9, 2022, the Reporting Person was granted 20,630 restricted stock units and options to purchase 30,945 shares of common stock of Codex DNA, Inc. (the "Issuer") under the Issuer's Outside Director Compensation Policy. However, the Reporting Person has declined the awards described above and any future annual awards until further notice. As a result, the transfer of such restricted stock units and options to purchase common stock did not in fact take place. Accordingly, as of June 15, 2022, the Reporting Person did not own any restricted stock units or options to purchase shares of common stock in the Issuer.